首页> 外国专利> GLP-1R GLP-2R COMPOSITIONS AND PEPTIDES HAVING DUAL GLP-1R AND GLP-2R AGONIST ACTIVITY

GLP-1R GLP-2R COMPOSITIONS AND PEPTIDES HAVING DUAL GLP-1R AND GLP-2R AGONIST ACTIVITY

机译:具有双重GLP-1R和GLP-2R激动剂活性的GLP-1R GLP-2R组合物和肽

摘要

The present invention is a composition having agonist activity for the GLP-2 receptor of the GLP-1 receptor and the human the human and peptides, as well as relates to its manufacturing method and use, the relative of the dual peptide of the GLP-1 receptor of human agonist activity (GLP-1R relative) is at least 0.01, and wherein the relative agonist activity of the dual peptide of the GLP-2 receptor of human (GLP-2R relative) is at least 0.01, and (GLP-1R relative) (GLP-2R relative) is at least 0.01. The invention also relates to analogues of the peptide lipid screen. The present invention also relates to a therapeutic or prophylactic treatment of diseases of the people, especially the brain and related diseases, or metabolic disorders such as gastrointestinal inflammation, short bowel syndrome and Crohn's disease.
机译:本发明是对GLP-1受体的GLP-2受体和人,人和肽具有激动剂活性的组合物,涉及其制备方法和用途,涉及GLP-二肽的相对肽。 1个人类激动剂活性受体(GLP-1R relative)至少为0.01,其中人类GLP-2受体双重肽(GLP-2R relative)的相对激动剂活性)至少为0.01,而(GLP-1R 相对)(GLP-2R 相对)至少为0.01。本发明还涉及肽脂质筛选的类似物。本发明还涉及对人的疾病,特别是脑部疾病和相关疾病,或诸如胃肠道炎症,短肠综合征和克罗恩氏病等代谢紊乱的治疗或预防。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号